These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8993432)

  • 1. Effects of PACAP-VIP hybrid peptides on gastric blood flow in conscious dogs.
    Naruse S; Nakamura T; Wei M; Ando E; Nokihara K; Wray V; Ozaki T; Kitagawa M; Hayakawa T
    Ann N Y Acad Sci; 1996 Dec; 805():511-5. PubMed ID: 8993432
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationship studies of PACAP-27 and VIP analogues.
    Kashimoto K; Nagano Y; Suitani Y; Hamanaka K; Mizumoto T; Tomizaki K; Takahata H; Nagamoto A; Ohata A; Yoshihara S; Ichimura T
    Ann N Y Acad Sci; 1996 Dec; 805():505-10. PubMed ID: 8993431
    [No Abstract]   [Full Text] [Related]  

  • 3. Frog vasoactive intestinal polypeptide and galanin: primary structures and effects on pituitary adenylate cyclase.
    Chartrel N; Wang Y; Fournier A; Vaudry H; Conlon JM
    Endocrinology; 1995 Jul; 136(7):3079-86. PubMed ID: 7540547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible key residues that determine left gastric artery blood flow response to PACAP in dogs.
    Wei MX; Hu P; Wang P; Naruse S; Nokihara K; Wray V; Ozaki T
    World J Gastroenterol; 2010 Oct; 16(38):4865-70. PubMed ID: 20939117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity studies on VIP: IV. The synthetic agonist helodermin-fragment-(1-28)-amide is a potent VIP-agonist with prolonged duration of tracheal relaxant activity.
    Jaeger E; Bauer S; Joyce MW; Foda HD; Berisha HI; Said SI
    Ann N Y Acad Sci; 1996 Dec; 805():499-504. PubMed ID: 8993430
    [No Abstract]   [Full Text] [Related]  

  • 6. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PACAP/VIP/secretin on pancreatic and gastrointestinal blood flow in conscious dogs.
    Naruse S; Ito O; Kitagawa M; Ishiguro H; Nakajima M; Hayakawa T
    Ann N Y Acad Sci; 1998 Dec; 865():463-5. PubMed ID: 9928050
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of cardiovascular responses to PACAP-27, PACAP-38, and vasoactive intestinal polypeptide.
    Champion HC; Santiago JA; Garrison EA; Cheng DY; Coy DH; Murphy WA; Ascuitto RJ; Ross-Ascuitto NT; McNamara DB; Kadowitz PJ
    Ann N Y Acad Sci; 1996 Dec; 805():429-41; discussion 442. PubMed ID: 8993422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs.
    Ito O; Naruse S; Kitagawa M; Ishiguro H; Ko S; Nakajima M; Hayakawa T
    Regul Pept; 1998 Nov; 78(1-3):105-12. PubMed ID: 9879753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles.
    Ashok B; Rubinstein I; Tsueshita T; Onyüksel H
    Peptides; 2004 Aug; 25(8):1253-8. PubMed ID: 15350692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.
    Ny L; Larsson B; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Andersson KE
    Br J Pharmacol; 1995 Dec; 116(7):2873-80. PubMed ID: 8680719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
    Murthy KS; Jin JG; Grider JR; Makhlouf GM
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
    Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
    Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a VIP-specific receptor in guinea pig tenia coli.
    Teng BQ; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.